Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy.
Theodoros MichelakosYurie SekigamiFilippos KontosCarlos Fernández-Del CastilloMotaz QadanVikram DeshpandeDavid T TingJeffrey W ClarkColin D WeekesAparna ParikhDavid P RyanJennifer Y WoTheodore S HongJill N AllenOnofrio CatalanoAndrew L WarshawKeith D LillemoeCristina R FerronePublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2021)
For resected TNT-treated BR/LA PDAC patients, the probability of surviving an additional length of time increases as a function of survival already accrued. Dynamic survival estimates may allow personalized follow-up and counseling.